Mutant SOD1 detoxification mechanisms in intact single cells

被引:0
|
作者
S Ganesan
G Rohde
K Eckermann
K Sroka
M K E Schaefer
C P Dohm
P Kermer
G Haase
F Wouters
M Bähr
J H Weishaupt
机构
[1] European Neuroscience Institute,Department of Neurology
[2] Cell Biophysics Group,undefined
[3] Waldweg 33,undefined
[4] DFG Research Center for Molecular Physiology of the Brain (CMPB),undefined
[5] University of Göttingen,undefined
[6] Waldweg 33,undefined
[7] Université de la Méditerranée,undefined
[8] INSERM,undefined
[9] Institut de Neurobiologie de la Méditerranée,undefined
[10] Equipe AVENIR,undefined
[11] campus de Luminy,undefined
来源
关键词
ALS; SOD1; FRET; chaperones; proteasome;
D O I
暂无
中图分类号
学科分类号
摘要
Mutant superoxide dismutase 1 (mtSOD1) causes dominantly inherited amyotrophic lateral sclerosis (ALS). The mechanism for mtSOD1 toxicity remains unknown. Two main hypotheses are the impairment of proteasomal function and chaperone depletion by misfolded mtSOD1. Here, we employed FRET/FLIM and biosensor imaging to quantitatively localize ubiquitination, as well as chaperone binding of mtSOD1, and to assess their effect on proteasomal and protein folding activities. We found large differences in ubiquitination and chaperone interaction levels for wild-type (wt) SOD1 versus mtSOD1 in intact single cells. Moreover, SOD1 ubiquitination levels differ between proteasomal structures and cytoplasmic material. Hsp70 binding and ubiquitination of wt and mtSOD1 species are highly correlated, demonstrating the coupled upregulation of both cellular detoxification mechanisms upon mtSOD1 expression. Biosensor imaging in single cells revealed that mtSOD1 expression alters cellular protein folding activity but not proteasomal function in the neuronal cell line examined. Our results provide the first cell-by-cell-analysis of SOD1 ubiquitination and chaperone interaction. Moreover, our study opens new methodological avenues for cell biological research on ALS.
引用
收藏
页码:312 / 321
页数:9
相关论文
共 50 条
  • [41] Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice
    Tobisawa, S
    Hozumi, Y
    Arawaka, S
    Koyama, S
    Wada, M
    Nagai, M
    Aoki, M
    Itoyama, Y
    Goto, K
    Kato, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 303 (02) : 496 - 503
  • [42] Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis
    Tan, Wenzhi
    Pasinelli, Piera
    Trotti, Davide
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (08): : 1295 - 1301
  • [43] TARGETING SOD1 INDUCES SYNTHETIC LETHAL KILLING OF PPM1D-MUTANT LEUKEMIA CELLS
    Zhang, Linda
    Hsu, Joanne
    Braekeleer, Etienne
    Chen, Chun-Wei
    Dayaram, Tajhal
    Murdaugh, Rebecca
    Richard, Rosemary
    Guzman, Anna
    Martell, Alejandra
    Callen, Elsa
    Urya, Hidetaka
    Waldvogel, Sarah
    Padilla, Jennifer
    Nussenzweig, Andre
    Huang, Shixia
    Coarfa, Cristian
    Takahashi, Koichi
    Anastas, Jamie
    Vassiliou, George
    Goodell, Margaret
    EXPERIMENTAL HEMATOLOGY, 2023, 124 : S165 - S165
  • [44] Nitrotyrosination contributes minimally to toxicity of mutant SOD1 associated with ALS
    Doroudchi, MM
    Minotti, S
    Figlewicz, DA
    Durham, HD
    NEUROREPORT, 2001, 12 (06) : 1239 - 1243
  • [45] Mutant SOD1 Instability: Implications for Toxicity in Amyotrophic Lateral Sclerosis
    Tiwari, Ashutosh
    Hayward, Lawrence J.
    NEURODEGENERATIVE DISEASES, 2005, 2 (3-4) : 115 - 127
  • [46] Ratio of mutant/normal SOD1 is an indicator for the progression of familial ALS
    Yamamoto, Y
    Sato, T
    Nakanishi, T
    Sugai, F
    Fukada, K
    Nagano, S
    Shimizu, A
    Sakoda, S
    ANNALS OF NEUROLOGY, 2004, 56 : S22 - S23
  • [47] Revisiting oxidative damage in ALS:: milcroglia, Nox, and mutant SOD1
    Boillee, Severine
    Cleveland, Don W.
    JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (02): : 474 - 478
  • [48] Prevention of mutant SOD1 motoneuron degeneration by copper chelators in vitro
    Azzouz, M
    Poindron, P
    Guettier, S
    Leclerc, N
    Andres, C
    Warter, JM
    Borg, J
    JOURNAL OF NEUROBIOLOGY, 2000, 42 (01): : 49 - 55
  • [49] Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
    Palomo, Gloria M.
    Granatiero, Veronica
    Kawamata, Hibiki
    Konrad, Csaba
    Kim, Michelle
    Arreguin, Andrea J.
    Zhao, Dazhi
    Milner, Teresa A.
    Manfredi, Giovanni
    EMBO MOLECULAR MEDICINE, 2018, 10 (10)
  • [50] Expression of mutant SOD1 inhibits retrograde axonal transport.
    Ligon, LA
    Wallace, KE
    Weber, N
    Holzbauer, EL
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 391A - 392A